期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 10, 期 4, 页码 277-285出版社
SPRINGER
DOI: 10.1007/s11910-010-0112-8
关键词
Mitochondrial disease; Encephalopathy; High-throughput sequencing; Next-generation sequencing; Oxidative phosphorylation; Electron transport chain
资金
- National Health and Medical Research Council (NHMRC)
- Muscular Dystrophy Association
Mitochondrial encephalopathy, the most common neurometabolic disorder, may be caused by mutations in approximately 100 different genes and may present with various symptoms, such as seizures, ataxia, myopathy, cognitive impairment, blindness, and stroke. Fewer than 50% of patients with mitochondrial encephalopathy receive a molecular diagnosis, primarily because of the large degree of clinical and genetic heterogeneity among patients and the limited knowledge of the genes involved in mitochondrial function. Here we review the most recent discoveries of genes associated with mitochondrial disease with variable neuropathology. All these genes have been identified via homozygosity mapping or linkage analysis; however, advances in sequencing technology indicate that the future of genetic diagnosis and disease gene discovery likely lies in high-throughput sequencing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据